Published in J Headache Pain on April 23, 2014
Dural administration of inflammatory soup or Complete Freund's Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion. J Headache Pain (2015) 0.81
The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci (2014) 0.81
Release of PACAP-38 in episodic cluster headache patients - an exploratory study. J Headache Pain (2016) 0.79
Cerebral reactivity in migraine patients measured with functional near-infrared spectroscopy. Eur J Med Res (2015) 0.77
Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage. J Headache Pain (2015) 0.75
Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res (1977) 9.45
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol (2013) 3.87
Evidence for a vascular factor in migraine. Ann Neurol (2011) 2.93
PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain (2008) 2.17
Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol (2009) 1.97
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia (2010) 1.88
Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia (1997) 1.78
Mast cell degranulation activates a pain pathway underlying migraine headache. Pain (2007) 1.74
The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache (2004) 1.68
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology (2010) 1.66
Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol (2005) 1.41
Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain (2003) 1.25
Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport (1993) 1.22
Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies. Cephalalgia (1997) 1.12
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia (2008) 1.09
New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet (2010) 1.01
The blood-brain barrier in migraine treatment. Cephalalgia (2008) 0.99
Migraine pain and nociceptor activation--where do we stand? Headache (2010) 0.95
Single dose pharmacokinetics of sumatriptan in healthy volunteers. Eur J Clin Pharmacol (1995) 0.95
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol (2004) 0.92
Effect of two novel CGRP-binding compounds in a closed cranial window rat model. Eur J Pharmacol (2007) 0.92
Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs (1994) 0.92
The science of migraine. J Vestib Res (2011) 0.91
The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia (2003) 0.89
Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia (2012) 0.89
Tracing neural connections to pain pathways with relevance to primary headaches. Cephalalgia (2011) 0.89
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. Cephalalgia (2011) 0.89
CGRP and NO in the trigeminal system: mechanisms and role in headache generation. Headache (2012) 0.89
Comparative pharmacological analysis of Rho-kinase inhibitors and identification of molecular components of Ca2+ sensitization in the rat lower urinary tract. Biochem Pharmacol (2007) 0.88
Neurogenic vasodilation of dural blood vessels is not mediated by cholinergic transmission in the anaesthetised rat. Eur J Pharmacol (2004) 0.88
The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery. Cephalalgia (2009) 0.87
Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia (2010) 0.86
VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium. Neuropeptides (2013) 0.85
Adrenergic, cholinergic and peptidergic nerve fibres in dura mater--involvement in headache? Cephalalgia (1981) 0.85
Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method. Cephalalgia (2012) 0.83
Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura. Cephalalgia (2010) 0.82
Sumatriptan clinical pharmacokinetics. Clin Pharmacokinet (1994) 0.82
Magnetic resonance angiography of the human middle meningeal artery: implications for migraine. J Magn Reson Imaging (2006) 0.82
Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine. J Mol Neurosci (2012) 0.81
The role of histamine in dural vessel dilation. Brain Res (2002) 0.79
Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat. Eur J Pharmacol (2011) 0.79
Middle meningeal artery dilatation in migraine. Headache (2009) 0.79
Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries. Eur J Pharmacol (2011) 0.79
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia (2010) 0.79
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache (2004) 1.39
Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther (2006) 0.99
Basic mechanisms of migraine and its acute treatment. Pharmacol Ther (2012) 0.97
Intracranial and extracranial arteries in migraine. Lancet Neurol (2013) 0.96
Current and prospective pharmacological targets in relation to antimigraine action. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.92
Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.91
Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Eur J Pharmacol (2006) 0.89
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia (2010) 0.88
Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries. Eur J Pharmacol (2009) 0.87
Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs. Expert Opin Pharmacother (2013) 0.80
Cranioselectivity of sumatriptan revisited: pronounced contractions to sumatriptan in small human isolated coronary artery. CNS Drugs (2014) 0.79
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia (2010) 0.79
Glutamate receptor antagonists in the management of migraine. Drugs (2014) 0.78
Functional reactivity of 5-HT receptors in human umbilical cord and maternal subcutaneous fat arteries after normotensive or pre-eclamptic pregnancy. J Hypertens (2006) 0.76
The phe-124-Cys and A-161T variants of the human 5-HT1B receptor gene are not major determinants of the clinical response to sumatriptan. Headache (2007) 0.76
Clonidine inhibits the canine external carotid vasodilatation to capsaicin by alpha2A/2C-adrenoceptors. Eur J Pharmacol (2006) 0.76
Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats. Eur J Pharmacol (2009) 0.76
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors. Eur J Pharmacol (2012) 0.75
Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries. Eur J Pharmacol (2002) 0.75
Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae. Life Sci (2012) 0.75
Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats. Basic Clin Pharmacol Toxicol (2013) 0.75